Cortagen 20 mg

Cortagen is a short peptide bioregulator developed within the Khavinson school of peptide research at the Saint Petersburg Institute of Bioregulation and Gerontology. Classified as a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Pro (AEDP), Cortagen was developed to investigate how minimal peptide sequences interact with cerebral cortex tissue and neuronal-pathway research models. Its compact structure positions Cortagen as a useful research compound for studying tissue-specific peptide signaling in laboratory contexts.

At the cellular and molecular level, Cortagen is studied for its proposed ability to engage with chromatin structure and modulate transcriptional activity within cortical neurons and neural cell models. Research observations within the Khavinson framework suggest that short bioregulator peptides interact with specific DNA regions to influence the expression of genes associated with neuronal signaling balance, neural tissue adaptation, and chromatin-associated epigenetic regulation in nervous-system cell systems. These observations are consistent with the broader proposition that short peptides act as gene-expression regulators within tissues from which their parent peptide complexes were originally extracted.

Research interest in Cortagen centers on nervous-system tissue gene expression studies, neuronal-pathway research models, and chromatin-organization investigations. Comparative work on tissue-specific bioregulators positions Cortagen alongside other neural-targeted oligopeptides used to explore peptidergic regulation of central nervous system biology in cell-culture and animal research models (Khavinson V.K., Anisimov V.N., 2009, Advances in Gerontology). Additional reports within the Khavinson tradition describe how the AEDP sequence influences neuronal gene-expression profiles in cortical research models, supporting continued laboratory investigation of Cortagen in neurobiology and chromatin biology research.

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling.

The development of short peptide bioregulators began in the 1970s at the Military Medical Academy in Saint Petersburg, where Professor Vladimir Khavinson and colleagues isolated peptide fractions from animal tissues that appeared to restore organ-specific function in experimental models. This work led to the founding of the Saint Petersburg Institute of Bioregulation and Gerontology and the systematic study of tissue-derived peptide complexes, including the cerebral cortex peptide complex from which Cortagen was later derived.

Cortagen was identified within this research program as a synthetic tetrapeptide bioregulator with the sequence Ala-Glu-Asp-Pro (AEDP), associated with cerebral cortex tissue and neuronal-pathway research models. Subsequent biochemical and molecular investigations explored how this peptide interacts with chromatin and influences neuronal gene expression, supporting the hypothesis that minimal peptide sequences can act as tissue-specific gene-expression modulators within neural and cortical cell systems.

Today, Cortagen is positioned within the wider family of Khavinson-school oligopeptides studied for nervous-system tissue gene expression, neuronal-pathway research, and chromatin-organization research in laboratory contexts.

1. Chromatin Interaction and Cortical Gene Expression

Within the Khavinson framework, Cortagen is proposed to interact with specific regions of double-stranded DNA and associated chromatin proteins, where it has been reported to influence gene-expression patterns in cortical neuron research models. This proposed mode of action positions Cortagen as a tool for investigating peptide-mediated chromatin engagement and transcriptional regulation in neural-derived cell systems.

2. Neuronal Signaling and Nervous-System Pathways

Research observations suggest that Cortagen engages with intracellular signaling pathways relevant to neuronal function, including pathways associated with neural membrane signaling research and neuronal-pathway adaptation research models. These observations make Cortagen a useful compound for exploring tissue-specific peptide signaling in cortical cell-culture systems.

3. Neuroimmune and Chromatin-Organization Research

Comparative work on short peptide bioregulators indicates that the AEDP sequence is associated with chromatin-organization changes in neural and immune cell models, including studies of cytokine-related signaling in neuroendocrine research. In nervous-system research models, Cortagen is investigated for its role in neural chromatin studies, neuroimmune signaling research, and age-related neural-gene-expression investigations.

4. Adaptive and Homeostatic Signaling

Khavinson-school bioregulators are described as adaptive peptide regulators that operate under physiological stress conditions. Cortagen is studied for its proposed contribution to neural-tissue homeostasis research, including models of age-related decline in neuronal-cell signaling and metabolic or ischemic-stress adaptation in cortical cell systems.

Research Applications

Conclusion

Cortagen is a Khavinson-school short peptide bioregulator with the sequence Ala-Glu-Asp-Pro, studied for its proposed role in nervous-system tissue gene expression, neuronal-pathway research, and chromatin-organization research. Its compact tetrapeptide structure and cortical-tissue positioning make Cortagen a valuable laboratory compound for exploring peptidergic regulation of gene expression in neurobiology research models.

Research Use Disclaimer

This product is intended for research and laboratory use only. It is designed exclusively for in vitro research purposes. All information provided is for educational and research reference only. This product is not intended for human or animal use. It is not a drug, food, or cosmetic and must not be marketed, labeled, or used as such. Use and handling are restricted to trained and qualified professionals.